2026-11-10T16:26:11.000Z · 2 days ago GeneDx announces new research to be presented at NSGC Annual Conference
Nov 10, 2026, 8:30 AM EST · 3 days ago GeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients
Nov 5, 2026, 8:30 AM EST · 8 days ago GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing MIRM
Oct 27, 2026, 3:28 PM EDT · 16 days ago Did GeneDx Holdings Corp. Insiders Breach their Fiduciary Duties to Shareholders?
Oct 23, 2026, 4:05 PM EDT · 20 days ago GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
2026-10-20T20:11:45.000Z · 23 days ago GeneDx enhances genome testing portfolio with long-read whole-genome sequencing
2026-10-20T12:40:35.000Z · 24 days ago GeneDx announces plans to enhance genome testing portfolio with lrWGS
Oct 20, 2026, 8:30 AM EDT · 24 days ago GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
2026-10-19T20:10:42.000Z · 24 days ago GeneDx advances clinical adoption of genomic medicine with 27 abstracts at ASHG
Oct 19, 2026, 4:05 PM EDT · 24 days ago GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
2026-10-07T12:35:11.000Z · 5 weeks ago GeneDx presents new findings on genomic newborn screening at ICoNS 2026
Oct 7, 2026, 8:30 AM EDT · 5 weeks ago GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
Oct 2, 2026, 8:30 AM EDT · 6 weeks ago GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
2026-09-22T15:50:25.000Z · 7 weeks ago GeneDx selloff after CMS news ‘probably too extreme,’ says Craig-Hallum
Sep 9, 2026, 8:30 AM EDT · 2 months ago GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
Sep 1, 2026, 6:55 AM EDT · 2 months ago GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
Aug 24, 2026, 8:30 AM EDT · 2 months ago GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's
Aug 11, 2026, 8:30 AM EDT · 3 months ago GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
Jul 30, 2026, 10:07 AM EDT · 3 months ago SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS
Jul 16, 2026, 4:05 PM EDT · 3 months ago GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
Jul 1, 2026, 5:06 PM EDT · 4 months ago WGS Stockholders Have Rights – If You Lost Money Investing in GeneDx Holdings Corp. Contact Robbins LLP for Information About Recovering Your Losses
Jun 16, 2026, 8:30 AM EDT · 5 months ago GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth
Jun 15, 2026, 9:30 AM EDT · 5 months ago Investor Notice of Barrack, Rodos & Bacine Concerning Its Lawsuit Against GeneDx Holdings Corp. (WGS)
Jun 10, 2026, 9:47 AM EDT · 5 months ago GENEDX HOLDINGS CORP. (WGS) INVESTOR ALERT Investors With Large Losses in GeneDe Holdings Corp. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Jun 10, 2026, 8:27 AM EDT · 5 months ago Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of GeneDx Holdings Corp. (WGS)
Jun 4, 2026, 3:30 PM EDT · 5 months ago GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS
May 26, 2026, 4:05 PM EDT · 5 months ago GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 20, 2026, 9:30 AM EDT · 5 months ago Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud
May 5, 2026, 8:09 AM EDT · 6 months ago GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
May 4, 2026, 4:05 PM EDT · 6 months ago GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
Apr 13, 2026, 4:05 PM EDT · 7 months ago GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
Mar 11, 2026, 5:00 PM EDT · 8 months ago Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
Mar 10, 2026, 8:30 AM EDT · 8 months ago GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
Mar 9, 2026, 8:30 AM EDT · 8 months ago GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership